The societal burden of HBV-related disease

South Korea

Bong Min Yang, Dong Joon Kim, Kwan Soo Byun, Hong Soo Kim, Joong Won Park, Sangjin Shin

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

To highlight the societal burden of HBV infection in South Korea, we estimated the annual societal costs of HBV-related diseases for the year 2005. For the economic costs of HBV-infection-related diseases estimate, baseline data was collected from the Health Insurance Review and Assessment Service (HIRA) database. To complement data from the HIRA database, hospital charts from sample hospitals was reviewed and patient surveys were conducted. In 2005, the societal cost of HBV infection was 1.937 trillion KRW, including 474,642 million KRW of direct costs and 1.463 trillion KRW of indirect costs. The cost breakdown by disease was CHB at 465,167 million KRW, cirrhosis at 533,449 million KRW, hepatocellular carcinoma at 863,940 million KRW, and liver transplantation at 74,635 million KRW. The estimated amount is equivalent to 0.24% of the 2005 Korean GDP. This analysis emphasizes how important the prevention and treatment of these diseases are from the perspectives of the Korean society.

Original languageEnglish
Pages (from-to)784-793
Number of pages10
JournalDigestive Diseases and Sciences
Volume55
Issue number3
DOIs
Publication statusPublished - 2010 Mar 1

Fingerprint

Republic of Korea
Costs and Cost Analysis
Health Insurance
Infection
Databases
Cost of Illness
Liver Transplantation
Hepatocellular Carcinoma
Fibrosis
Economics

Keywords

  • Cost of illness
  • Hepatitis B
  • Prevalence
  • South Korea

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

The societal burden of HBV-related disease : South Korea. / Yang, Bong Min; Kim, Dong Joon; Byun, Kwan Soo; Kim, Hong Soo; Park, Joong Won; Shin, Sangjin.

In: Digestive Diseases and Sciences, Vol. 55, No. 3, 01.03.2010, p. 784-793.

Research output: Contribution to journalArticle

Yang, Bong Min ; Kim, Dong Joon ; Byun, Kwan Soo ; Kim, Hong Soo ; Park, Joong Won ; Shin, Sangjin. / The societal burden of HBV-related disease : South Korea. In: Digestive Diseases and Sciences. 2010 ; Vol. 55, No. 3. pp. 784-793.
@article{e26f8aeb946a4b94bbb99495b3738116,
title = "The societal burden of HBV-related disease: South Korea",
abstract = "To highlight the societal burden of HBV infection in South Korea, we estimated the annual societal costs of HBV-related diseases for the year 2005. For the economic costs of HBV-infection-related diseases estimate, baseline data was collected from the Health Insurance Review and Assessment Service (HIRA) database. To complement data from the HIRA database, hospital charts from sample hospitals was reviewed and patient surveys were conducted. In 2005, the societal cost of HBV infection was 1.937 trillion KRW, including 474,642 million KRW of direct costs and 1.463 trillion KRW of indirect costs. The cost breakdown by disease was CHB at 465,167 million KRW, cirrhosis at 533,449 million KRW, hepatocellular carcinoma at 863,940 million KRW, and liver transplantation at 74,635 million KRW. The estimated amount is equivalent to 0.24{\%} of the 2005 Korean GDP. This analysis emphasizes how important the prevention and treatment of these diseases are from the perspectives of the Korean society.",
keywords = "Cost of illness, Hepatitis B, Prevalence, South Korea",
author = "Yang, {Bong Min} and Kim, {Dong Joon} and Byun, {Kwan Soo} and Kim, {Hong Soo} and Park, {Joong Won} and Sangjin Shin",
year = "2010",
month = "3",
day = "1",
doi = "10.1007/s10620-009-0786-4",
language = "English",
volume = "55",
pages = "784--793",
journal = "American Journal of Digestive Diseases",
issn = "0002-9211",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - The societal burden of HBV-related disease

T2 - South Korea

AU - Yang, Bong Min

AU - Kim, Dong Joon

AU - Byun, Kwan Soo

AU - Kim, Hong Soo

AU - Park, Joong Won

AU - Shin, Sangjin

PY - 2010/3/1

Y1 - 2010/3/1

N2 - To highlight the societal burden of HBV infection in South Korea, we estimated the annual societal costs of HBV-related diseases for the year 2005. For the economic costs of HBV-infection-related diseases estimate, baseline data was collected from the Health Insurance Review and Assessment Service (HIRA) database. To complement data from the HIRA database, hospital charts from sample hospitals was reviewed and patient surveys were conducted. In 2005, the societal cost of HBV infection was 1.937 trillion KRW, including 474,642 million KRW of direct costs and 1.463 trillion KRW of indirect costs. The cost breakdown by disease was CHB at 465,167 million KRW, cirrhosis at 533,449 million KRW, hepatocellular carcinoma at 863,940 million KRW, and liver transplantation at 74,635 million KRW. The estimated amount is equivalent to 0.24% of the 2005 Korean GDP. This analysis emphasizes how important the prevention and treatment of these diseases are from the perspectives of the Korean society.

AB - To highlight the societal burden of HBV infection in South Korea, we estimated the annual societal costs of HBV-related diseases for the year 2005. For the economic costs of HBV-infection-related diseases estimate, baseline data was collected from the Health Insurance Review and Assessment Service (HIRA) database. To complement data from the HIRA database, hospital charts from sample hospitals was reviewed and patient surveys were conducted. In 2005, the societal cost of HBV infection was 1.937 trillion KRW, including 474,642 million KRW of direct costs and 1.463 trillion KRW of indirect costs. The cost breakdown by disease was CHB at 465,167 million KRW, cirrhosis at 533,449 million KRW, hepatocellular carcinoma at 863,940 million KRW, and liver transplantation at 74,635 million KRW. The estimated amount is equivalent to 0.24% of the 2005 Korean GDP. This analysis emphasizes how important the prevention and treatment of these diseases are from the perspectives of the Korean society.

KW - Cost of illness

KW - Hepatitis B

KW - Prevalence

KW - South Korea

UR - http://www.scopus.com/inward/record.url?scp=77949331566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949331566&partnerID=8YFLogxK

U2 - 10.1007/s10620-009-0786-4

DO - 10.1007/s10620-009-0786-4

M3 - Article

VL - 55

SP - 784

EP - 793

JO - American Journal of Digestive Diseases

JF - American Journal of Digestive Diseases

SN - 0002-9211

IS - 3

ER -